MedPath

Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2

Not Applicable
Completed
Conditions
Death; Neonatal
Intraventricular Haemorrhage Neonatal
Interventions
Procedure: Delayed cord clamping DCC
Procedure: Umbilical cord milking UCM
Registration Number
NCT03019367
Lead Sponsor
Sharp HealthCare
Brief Summary

This study is being done to find out whether umbilical cord milking (UCM) is at least as good as or better than delayed cord clamping (DCC) to reduce bleeding in the brain or prevent death in premature newborns. The investigators will study short and long term outcomes of infants delivered before 32 weeks gestation that receive either UCM or DCC.

\* The trial was stopped by the DSMB for safety in the small strata. They subsequently allowed for continuation of the trial in infants 29-32+6 wk GA.

Detailed Description

Aim 1. Compare the incidence of severe intraventricular hemorrhage (IVH) and/or death in premature newborns \<33 weeks gestational age (GA) delivered by C/S receiving UCM to those receiving DCC.

Hypothesis1: First demonstrate infants in the UCM group are not inferior to the DCC group (reject H10).

Hypothesis2: If H1 is true, demonstrate lower incidence of severe IVH and/or death in UCM infants compared to DCC.

Aim 2. Compare the safety and efficacy profiles of premature newborns \<33 weeks GA delivered by C/S receiving UCM vs. DCC during their hospitalization.

Hypothesis3: UCM group will have a decreased need for resuscitation interventions with no differences in bilirubin or polycythemia compared to DCC.

Hypothesis4: UCM group will have improved blood pressures in the first 24 hours of life compared to DCC.

Aim 3 (exploratory). To compare the outcomes of premature newborns \<33 weeks GA delivered by C/S (Cesarean section) (from Aims 1 and 2) with those born by V/D (vaginal delivery) receiving UCM or DCC.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1201
Inclusion Criteria
  • 23 to 32 +6 Gestational age (currently enrolling 29 to 32+6 weeks)
  • Multiples without Twin-to-twin Transfusion Syndrome (TTTS)
Exclusion Criteria
  • Congenital anomalies
  • Major cardiac defects
  • Placental abruption or previa with hemorrhage
  • Cord prolapse
  • Hydrops
  • Bleeding Accreta
  • Monochorionic multiples with evidence of TTTS
  • Fetal or maternal risk (i.e. compromise)
  • Parents declined study
  • Unlikely to return for 2 yr Follow Up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Delayed cord clamping DCCDelayed cord clamping DCCDelayed clamping of the umbilical cord for at least 60 seconds.
Umbilical cord milking UCMUmbilical cord milking UCMMilking the umbilical cord 4 times towards the infant at a speed of 20cm/2seconds.
Primary Outcome Measures
NameTimeMethod
Incidence of severe IVH or deathThrough study completion at death or discharge, up to 6 months corrected gestational age (CGA)

Severe intraventricular hemorrhage of grade 3 or 4 or death

Secondary Outcome Measures
NameTimeMethod
All Grade IVHThrough study completion at discharge, up to 6 months corrected gestational age (CGA)

Any intraventricular hemorrhage (grades 1-4)

Severe IVH (Grade 3 or 4)Through study completion at discharge, up to 6 months corrected gestational age (CGA)

Severe intraventricular hemorrhage (bleeding in the brain parenchyma and/or ventricular dilation)

Delivery room interventionsIn the first 10 minutes of life

Resuscitation interventions including positive pressure ventilation, continuous positive airway pressure, intubation, chest compressions and medications

Hemoglobin/Hematocrit at 4 hours4 +/- 2 hours of life

hemoglobin/hematocrit

Blood pressures in the first 24 hours of lifeIn the first 24 hours of life

Blood pressure on admission, 6, 12, 18 and 24 hours of life

Incidence of Severe IVH or death in infants <28 weeks gestationThrough study completion at discharge, up to 6 months corrected gestational age (CGA)

Severe intraventricular hemorrhage (grade 3 or 4) in infants born under 28 weeks gestational age

Trial Locations

Locations (18)

John H. Stroger, Jr. Hospital of Cook County

🇺🇸

Chicago, Illinois, United States

Loma Linda Medical Center

🇺🇸

Loma Linda, California, United States

LAC+USC Medical Center

🇺🇸

Los Angeles, California, United States

Governors of University of Alberta

🇨🇦

Edmonton, Alberta, Canada

Christiana Care

🇺🇸

Newark, Delaware, United States

University of Alabama

🇺🇸

Birmingham, Alabama, United States

PIH Health Good Samaritan Hospital

🇺🇸

Los Angeles, California, United States

University of California, Irvine Medical Center

🇺🇸

Orange, California, United States

Sharp Grossmont Hospital

🇺🇸

San Diego, California, United States

Sharp Mary Birch Hospital for Women and Newborns

🇺🇸

San Diego, California, United States

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

Cincinnati Children's Hospital

🇺🇸

Cincinnati, Ohio, United States

Providence St. Vincent Medical Center

🇺🇸

Portland, Oregon, United States

St. Louis University

🇺🇸

Saint Louis, Missouri, United States

Magee-Womens Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

University of Utah

🇺🇸

Salt Lake City, Utah, United States

Cork University Maternity Hospital

🇮🇪

Cork, Ireland

University of ULM

🇩🇪

Ulm, Baden-Wurttemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath